In conclusion, PNPLA3 148M is over-represented in HCC patients, in particular in those with ALD&NAFLD, where it is associated with earlier presentation at a less advanced stage of liver disease. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.